You are worth tens of billions before you come to the system?

The next day, Lin Zitai received the news from Born and asked about the next plan. They had basically reached an internal agreement and would try their best to cooperate with Novartis's acquisition of Merck.

Lin Zitai lamented that the strength of the Jewish consortium was more terrifying than he imagined. In less than 48 hours, it could decide the ownership of a company worth hundreds of billions.

He also tells about his plans...

……

In early October, Novartis provided information to the New York Stock Exchange and applied for an indefinite trading suspension on the grounds of major acquisition and merger plans and changes in equity, which was approved by the New York Stock Exchange.

As soon as the news came out, the world was in an uproar.

Major mergers and acquisitions? Equity changes?

Does this mean Novartis is starting to take action against Merck?

But where did Lin Zitai get his confidence?

Even though Novartis Group's market has recovered recently, its market value is only 1200 billion. Even if Merck's stock price has fallen recently, it still has more than 3600 billion.

The size is three times different, where does the confidence come from?

Less than an hour after the news of Novartis’ trading suspension was revealed, Lin Zitai indirectly told the world where his confidence came from.

Merck has issued three important announcements in succession, two of which are changes in shareholder equity, and one of which is a trading suspension starting today.

The Saudi sovereign fund sold an investment company that held 336% of Merck's shares for US$11.2 billion to Novartis Investments.

Pioneer transferred its 397.85% stake in Merck for US$10.9 billion, and the transferor was also Novartis Investment.

Novartis invested US$733.85 billion and successfully held 22.1% of Merck's shares, becoming the largest shareholder.

In order to counter Novartis's malicious merger, Merck's board of directors decided after discussion to apply for a three-day trading suspension.

As soon as the news was announced, Internet social platforms in various countries fell into deathly silence.

Not long after, Lin Zitai’s name appeared on the front pages of various countries, and the comment sections were filled with exclamations from netizens from all over the world.

"Damn it, if this fucking merger succeeds, isn't Lin Zitai going to heaven?"

"Everyone, please do the math quickly. Is Boss Lin going to become the richest man in the world?"

"Hey, Forbes is calling you, don't pretend to be dead, get up and update the list quickly. Is this something he can do with a net worth of US$182 billion?"

Novartis's acquisition of Merck was a project led by Lin Zitai, but it was still hotly searched by netizen @ on Forbes.

After all, in the list released at the beginning of the year, Lin Zitai ranked fifth on the domestic wealth list with a net worth of US$182 billion.

The things he has done now, even if he picks one at random, are not like what he can accomplish with 182 billion US dollars.

Not to mention too much, based on the market value of Novartis Group of US$1250 billion, Lin Zitai holds 33.4% of the shares, and his personal wealth has reached US$417 billion.

It would probably be a bit impolite if Lin Zitai was allowed to be ridden on the head by Xiaoma Laoma, Wanda Laowang and Hengtai Lao Xu.

When the editor-in-chief of Forbes got the news, they were also distressed. They had already said in the comments on the ranking at the beginning of the year that although Lin Zitai was ranked fifth in China, he was actually number one in China.

After all, the Prince Group has not yet been listed and has not raised external funds. It also issued credit bonds worth 200 billion, so it is difficult to estimate an accurate market value.

However, this overwhelming heat.

If you don’t give it a try, it would be blasphemy against media studies.

With a wave of his hand, the editor-in-chief of Forbes directly announced that starting from this month, real-time updates will be made every month, and a summary will be made at the end of the year.

Once the list was updated, Lin Zitai became the richest man in China and the third richest man in the world with a wealth of US$947.9 billion, second only to Amazon Bezos and Bill Gates.

US$239.6 billion comes from Mojin 44.5%.

US$417 billion comes from Novartis Group, 33.4%.

Prince Group is still the most difficult to evaluate, but fortunately this year it issued 2000 billion yuan in credit bonds, at least it has a reference object, so it gave it a valuation of 291 billion US dollars.

Equivalent to RMB 6493.6 billion.

Directly surpassing the second place by more than 3800 billion, which is almost equal to the total wealth of the 2nd to 5th place.

Once the list was updated, it aroused discussion among domestic netizens. As for whether Novartis can acquire Merck, it is no longer their concern.

After all, laymen can only see the excitement, and changes in wealth are the most intuitive manifestation...

……

"So, they are not willing to be merged?" "That's right, we can't force them."

"Mr. Bone, please do me a favor."

"Please say."

Lin Zitai contacted Bohn, hoping that the other party could help him meet with BlackRock and the person in charge of State Street Fund.

Merck applied for a trading suspension, unwilling to be merged.

They still have a 11.3% share gap, nearly 2.8 million shares, and it is too difficult to purchase them on the secondary market.

Start with public transactions, and take more and count the more.

While Bohn was contacting BlackRock and State Street, Lin Zitai also met with the person in charge of Samsung Mitsui Dai-ichi Life.

"Everyone, the decisive battle will begin in three days. I hope everyone can go all out."

Lin Zitai plans to raise another amount of funds and prepare for the worst.

After all, it is a certainty that Novartis Group will acquire Merck, and it has to be launched.

Merck's board of directors holds a total of 26% of the shares, while they hold 22.1%. The gap between the two sides is very small, only 3.9%.

Novartis Investment can reach 33.4%, and Merck's board of directors can also reach this shareholding.

Even though they are supported by BlackRock and State Street, they only hold 8.3% of the shares.

There is bound to be a fundraising battle in three days, so they must raise enough funds.

Because not only the board of directors of Merck will rush to raise funds, but also retail investors in the market will rush to raise funds, raise the stock price, and take advantage of the opportunity to make profits.

So in the end, the fight is actually about how much money everyone has. It's like fighting a war, and the fight is about logistical supplies.

Lin Zitai said: "We need to raise another US$1000 billion. I have no problem raising US$ billion. What about you?"

Several people opened their eyes and looked at each other.

Saito Shengli frowned: "Mr. Lin, isn't 1000 billion US dollars too much? I probably can't use so much funds."

Although they all have banks in their names, they have invested nearly 600 billion U.S. dollars, and now they want another 600 billion U.S. dollars. Even a nuclear-powered money printing machine at home cannot withstand it.

Lin Zitai said softly: "As far as I know, Merck has US$480 billion in liquidity on its books, and I don't know how much more it will prepare in the future. Our current available funds are only US$262 billion. Even if we add another 1000 billion, it will be 1262 billion."

And compared with them, we still have a 3.9% share gap. Mr. Saito, how much do you think 1262 billion is? "

Lee Jae-yong pondered for a long time: "Samsung has no problem, it can still afford 250 billion US dollars."

Kazuo Aoi looked troubled and looked at Saito Shengli. Among the three companies, Mitsui Group held the smallest amount of funds.

Of the US$175 billion raised last time, US$75 billion was invested in their name by Dai-ichi Life.

Now they have to spend another 175 billion US dollars. Their Mitsui Group is really short of money and cannot come up with this huge amount of funds.

Saito Shengli pondered for a long time, frowning: "Mr. Lin, where did your US$400 billion come from?"

Lin Zitai smiled faintly: "Mr. Saito, you don't need to worry about my source of funds. If you don't have money, I can pay all of it, but accordingly, your shares will be diluted."

This time the funding gap was so big and the need was so urgent, Lin Zitai immediately thought of his motherland.

The Bank of China learned that Novartis's acquisition of Merck had come to an end, and with a wave of its hand, it offered full support with no upper limit on funding.

I have to say, it is really good to enjoy the shade under the big tree, and it feels good to have someone covering you.

Saito Seungri looked solemn. He also guessed that the Chinese national team was entering the field and no longer hesitated: "It is no problem for Mitsui Group and Dai-ichi Life to invest 350 billion."

Although the money required is a bit high, they can still squeeze it out if they squeeze. After all, they are the most powerful life insurance group in Japan, controlling 25% of the country's pension funds.

"Everyone, let's start with the dirty talk. The funds must be received within three days. If the funds are not received after two days, I will introduce other institutions."

Lin Zitai looked cold and did not hide it. He directly told them that there was another force that hoped to enter the field at the last moment and enjoy the fruits of victory.

Whether they can seize this opportunity depends on themselves. If they make wedding clothes for others, they cannot blame them. (End of chapter)